We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
Medha Goyal*
Affiliation:
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
Ruchi Nanavati
Affiliation:
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
*
Address for correspondence: Dr. Medha Goyal, DM, Department of Neonatology, 10th Floor, MSB, KEM Hospital, Parel, Mumbai 400 012, India. Tel: +91 9911961790. E-mail: medha_kv@yahoo.com
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
Michaëlsson, M, Engle, MA.Congenital complete heart block: an international study of the natural history. Cardiovasc Clin.1972; 4: 85–101.Google Scholar
2
Buyon, JP, Hiebert, R, Copel, J, et al.Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol.1998; 31: 1658–1666.CrossRefGoogle ScholarPubMed
Ho, SY, Esscher, E, Anderson, RH, Michaëlsson, M.Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol.1986; 58: 291–294.CrossRefGoogle ScholarPubMed
5
Brucato, A.Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford)2008; 47 Suppl 3: iii35–7.CrossRefGoogle ScholarPubMed
6
Friedman, DM, Llanos, C, Izmirly, PM, et al.Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum.2010; 62: 1138–1146.CrossRefGoogle Scholar
7
Buyon, JP, Clancy, RM, Friedman, DM.Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med.2009; 265: 653–662.CrossRefGoogle ScholarPubMed
8
Shokrzadeh, A, Maltret, A, Morel, N, et al.Longitudinal analysis of fetal ventricular rate for risk stratification in immune congenital heart block. Fetal Diagn Ther.2021; 48: 1–8.CrossRefGoogle ScholarPubMed
Jaeggi, ET, Hamilton, RM, Silverman, ED, Zamora, SA, Hornberger, LK.Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol.2002; 39: 130–137.CrossRefGoogle ScholarPubMed
12
Glikson, M, Nielsen, JC, Kronborg, MB, et al.2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J.2021; 42: 3427–3520.CrossRefGoogle ScholarPubMed